Bitmine acquired 27,180 Ethereum tokens last week, increasing its total holdings to nearly 6 million ETH, or about 4.9% of the total supply. The company is close to its goal of owning 5% of all Ethereum, needing around 144,000 more tokens. Bitmine also stakes over 5 million ETH, expecting hundreds of millions in annual returns, and holds combined assets worth $15.8 billion. Positive shifts in ETH-BTC price dynamics and upcoming U.S. crypto legislation may further impact its strategy.
Bitmine's recent Ethereum acquisition is context for readers. As of Sep 14, 2026 21:05 WIB, 25 of 50 major cryptocurrencies rose on Pluang, 24 fell. ENJ fell 3.41% to Rp461 with 100% buy activity; SNX dropped 2.92% to Rp3.722 with full buy orders; ALGO rose 2.75% to Rp1.682 with 83% buy activity and 17% sell.
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
